Symbol="LIFE"
AssetType="Common Stock"
Name="aTyr Pharma Inc"
Description="aTyr Pharma, Inc., a clinical-stage biotherapeutics company, is dedicated to the discovery and development of drugs based on new immune pathways in the United States. The company is headquartered in San Diego, California."
CIK="1339970"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="3545 JOHN HOPKINS COURT, STE #250, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="105535000"
EBITDA="-47458000"
PERatio="None"
PEGRatio="0"
BookValue="1.862"
DividendPerShare="0"
DividendYield="0"
EPS="-1.24"
RevenuePerShareTTM="0.268"
ProfitMargin="0"
OperatingMarginTTM="-4.601"
ReturnOnAssetsTTM="-0.261"
ReturnOnEquityTTM="-0.468"
RevenueTTM="10386000"
GrossProfitTTM="-32422000"
DilutedEPSTTM="-1.24"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="13.26"
AnalystTargetPrice="23.2"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="37.76"
PriceToBookRatio="0.831"
EVToRevenue="12.47"
EVToEBITDA="0.101"
Beta="1.237"
num_52WeekHigh="3.75"
num_52WeekLow="1.555"
num_50DayMovingAverage="2.023"
num_200DayMovingAverage="2.147"
SharesOutstanding="57046000"
DividendDate="2019-07-01"
ExDividendDate="None"
symbol="LIFE"
open="1.84"
high="1.90"
low="1.79"
price="1.85"
volume="287423.00"
latest_trading_day="2023-08-25"
previous_close="1.84"
change="0.01"
change_percent="0.5435%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="52"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="48"
Volume_recent_avg="529096"
Change_recent_avg="-0.01"
Delta_recent_avg="0.11"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-0.48"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="48"
Aroon_momentum_negative="52"
image_negative_thumbnail_id_1="1117"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0150.jpeg"
image_negative_thumbnail_id_2="163"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0013.jpeg"
image_neutral_thumbnail_id_1="535"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0064.jpeg"
image_neutral_thumbnail_id_2="551"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0048.jpeg"
image_positive_thumbnail_id_1="965"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0127.jpeg"
image_positive_thumbnail_id_2="1166"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Negative_0187.jpeg"
image_professor_thumbnail_id_1="1177"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
image_professor_thumbnail_id_2="1174"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
